FloDesign Sonics Inc., a Wilbraham, MA-based developer of a novel acoustic technology, closed a $10m Series A financing round.
The round was led by Bright Capital with participation from Ventry Industries and individual investors James Waters (founder of Waters Corp) and life science veteran Jonathan Fleming of Oxford Biosciences.
The company intends to use the funds to further develop their core acoustic separation technology platform and fund commercialization efforts in the bioprocessing market application.
Led by founder and CTO Dr. Bart Lipkens, CEO Stanley Kowalski III, and co-founder and Executive Vice President Louis Masi, FloDesign Sonics leverages innovations in the use of 3D acoustic standing waves to capture, separate and purify without using physical membranes, chemicals, or centrifugation.
Its proprietary technology has numerous applications in a variety of markets including life sciences, oil and gas, food and beverage and industrial processing.
The first commercial application is in bioprocess separations where the company is applying acoustic technology to the manufacturing of life saving bio-pharmaceuticals.